– non-invasive and designed for real-time monitoring of cardiovascular health using sweat-based biomarkers such as troponin-I, NT-proBNP, lactate, cortisol, and pH indicators.
– Integrates multi-channel ECG acquisition with biochemical sensing via a wearable patch during physical activities like gym exercises or running.
– Provides three warning signals: Normal (keep monitoring), consult medical professional, emergency.
The development of MyoBioScan represents important progress in healthcare technology originating from indo-US collaboration.KSOU’s contribution underscores India’s potential to influence global innovation through academic expertise. The emphasis on non-invasive techniques offers promise for transforming cardiac care delivery by making preventive diagnostics affordable and widely accessible.
Pilot study results validate the technical viability of sweat-based biomarkers for real-time cardiovascular monitoring while highlighting users’ demand for reliability in novel medical devices. If scaled effectively post-validation stages, MyoBioScan could alleviate diagnostic burdens on healthcare systems globally-especially in rural areas where access to specialized cardiac care is limited.By fostering academic research collaborations like this one between institutions abroad and within India, there lies immense scope to leverage science-centric partnerships aimed at addressing global health challenges through localized innovation.
Read more: The Hindu